These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 9871543

  • 1. Synthesis of C2 alkynylated purines, a new family of potent inhibitors of cyclin-dependent kinases.
    Legraverend M, Ludwig O, Bisagni E, Leclerc S, Meijer L.
    Bioorg Med Chem Lett; 1998 Apr 07; 8(7):793-8. PubMed ID: 9871543
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Synthesis and in vitro evaluation of novel 2,6,9-trisubstituted purines acting as cyclin-dependent kinase inhibitors.
    Legraverend M, Ludwig O, Bisagni E, Leclerc S, Meijer L, Giocanti N, Sadri R, Favaudon V.
    Bioorg Med Chem; 1999 Jul 07; 7(7):1281-93. PubMed ID: 10465404
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cyclin-dependent kinase inhibitors block proliferation of human gastric cancer cells.
    Iseki H, Ko TC, Xue XY, Seapan A, Hellmich MR, Townsend CM.
    Surgery; 1997 Aug 07; 122(2):187-94; discussion 194-5. PubMed ID: 9288122
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis and biological activity of olomoucine II.
    Krystof V, Lenobel R, Havlícek L, Kuzma M, Strnad M.
    Bioorg Med Chem Lett; 2002 Nov 18; 12(22):3283-6. PubMed ID: 12392733
    [Abstract] [Full Text] [Related]

  • 9. Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds.
    Havlícek L, Hanus J, Veselý J, Leclerc S, Meijer L, Shaw G, Strnad M.
    J Med Chem; 1997 Feb 14; 40(4):408-12. PubMed ID: 9046330
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors.
    Chang YT, Gray NS, Rosania GR, Sutherlin DP, Kwon S, Norman TC, Sarohia R, Leost M, Meijer L, Schultz PG.
    Chem Biol; 1999 Jun 14; 6(6):361-75. PubMed ID: 10375538
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity.
    Alessi F, Quarta S, Savio M, Riva F, Rossi L, Stivala LA, Scovassi AI, Meijer L, Prosperi E.
    Exp Cell Res; 1998 Nov 25; 245(1):8-18. PubMed ID: 9828096
    [Abstract] [Full Text] [Related]

  • 16. Chemical inhibitors of cyclin-dependent kinases.
    Meijer L.
    Prog Cell Cycle Res; 1995 Nov 25; 1():351-63. PubMed ID: 9552377
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chemical inhibitors of cyclin-dependent kinases.
    Meijer L, Kim SH.
    Methods Enzymol; 1997 Nov 25; 283():113-28. PubMed ID: 9251015
    [No Abstract] [Full Text] [Related]

  • 19. 2,6,8,9-tetrasubstituted purines as new CDK1 inhibitors.
    Moravec J, Krystof V, Hanus J, Havlícek L, Moravcová D, Fuksová K, Kuzma M, Lenobel R, Otyepka M, Strnad M.
    Bioorg Med Chem Lett; 2003 Sep 15; 13(18):2993-6. PubMed ID: 12941319
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.